{"nct_id":"NCT00871741","title":"Feasibility Study of GlaxoSmithKline Biologicals' GSK2202083A Vaccine in Healthy Infants at 3, 5 and 11 Months of Age.","status":"TERMINATED","status_verified_date":"2017-04","start_date":"2009-04-01","start_date_type":null,"primary_completion_date":"2009-06-25","primary_completion_date_type":"ACTUAL","completion_date":"2009-06-25","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["GSK"]}